SIG | Lead Contact |
AIMS | martin.brown@ppd.com |
Benefit Risk | shahrul.mt-isa@msd.com; mboeri@rti.org |
Biomarkers | nicole_2.kraemer@boehringer-ingelheim.com; guillaume.desachy@astrazeneca.com |
CSM/QTL | timothy.e.rolfe@gsk.com; sshepher@amgen.com |
Data Science | julia.chernova@bayer.com |
Data Sharing | rebecca.sudlow@roche.com; mimmi.sundler@astrazeneca.com |
Decision Making | alex.l.carlton@gsk.com; tguerin@theravance.com |
Historical Data | nicky.x.best@gsk.com; simon.wandel@novartis.com |
HTA | lara.wolfson@merck.com |
Launch & Lifecycle | alexander.schacht@veramed.co.uk; jenny.devenport@roche.com |
Neuroscience Estimands | hans_ulrich.burger@roche.com |
Oncology Estimands | kaspar.rufibach@roche.com; evgeny.degtyarev@novartis.com |
Pre-Clinical | eloisa.i.brook@gsk.com |
Regulatory | jurgen.hummel@ppd.com |
Real World Data (RWD) | Josephine.Wolfram@astellas.com |
Small Populations | andreas.kaiser@bayer.com; francois.aubin@vennlife.com |
Subgroup Analysis | david.j.svensson@astrazeneca.com |
Vaccines | fabian.s.tibaldi@gsk.com |
Visualisation | bodo.kirsch@bayer.com |